The GLP-1 telehealth market has exploded in 2026. With dozens of providers now offering compounded semaglutide and tirzepatide, choosing the right one has become genuinely difficult. We spent three months evaluating the top contenders — signing up, testing the patient experience, and analyzing clinical protocols — to build this ranking.